Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover study.

@article{Lipton2009ConsistencyOR,
  title={Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover study.},
  author={Richard B. Lipton and David W Dodick and James U. Adelman and Robert G Kaniecki and Shelly E Lener and Jonathan D White and Andrew C. Nelsen},
  journal={Cephalalgia : an international journal of headache},
  year={2009},
  volume={29 8},
  pages={826-36}
}
Two identical randomized, placebo-controlled, crossover studies were conducted to evaluate consistency of response to sumatriptan/naproxen sodium 85/500 mg (S/NS) over four attacks in adults with migraine. Patients were instructed to treat within 1 h of pain onset while pain was mild. Co-primary end-points were pain-free response at 2 h (2hPF) and 24-h sustained pain-free response (24hSPF) calculated as percentages of all attacks. In Study 1, 570 patients treated 1693 attacks with S/NS and 424… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Sumatriptan/Naproxen Sodium: A Review in Migraine

Drugs • 2015
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…